GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Stryker Corporation (SYK) [hlAlert]

Rating:
Buy SYK
up 19.25 %

Stryker Corporation (SYK) rated Buy with price target $102 by Argus

Posted on: Wednesday,  Jun 11, 2014  12:00 AM ET by Argus

Argus rated Buy Stryker Corporation (NYSE: SYK) on 06/11/2014, when the stock price was $84.76. Since
then, Stryker Corporation has gained 19.25% as of 01/08/2016's recent price of $101.08.
If you would have followed this Argus's recommendation on SYK, you would have gained 19.25% of your investment in 576 days.

Stryker Corporation (Stryker) is a medical technology company with a range of products in orthopaedics and a presence in other medical specialties. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose and throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. The Company operates in two business segments: Orthopaedic Implants and MedSurg Equipment. The Orthopaedic Implants segment sells orthopaedic reconstructive (hip, knee and shoulder), trauma, craniomaxillofacial and spinal implant systems; bone cement; and the bone growth factor OP-1. The MedSurg Equipment segment sells surgical equipment; surgical navigation systems; endoscopic, communications and digital imaging systems; as well as patient handling and emergency medical equipment.

Argus Research is an independent research firm, and our business is producing, distributing and marketing high-quality investment and economic research. Our recommendations - BUY, HOLD and SELL - reflect the judgment of an analyst about a company's prospects as an investment in terms of value, expected growth and risks. Argus Research does not bring companies public, advise companies on mergers and acquisitions, broker trades, make markets in stocks or manage money. Our independence allows us to make critical judgments about companies that we might not be so free to make were we competing for a firm's underwriting business. Because we're not a broker/dealer, we don't have "inventory" of a stock that we have to move with a tainted recommendation. We have developed a six-point system for analyzing the stocks in our Universe of Coverage. We believe that this system
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/11/2014 12:00 AM Buy
None
84.76 102.00
as of 10/17/2014
1 Week down  -1.97 %
1 Month down  -4.36 %
3 Months down  -1.75 %
1 YTD down  -5.28 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy